TDOC
Teladoc Health, Inc.
NYSE · Healthcare · Medical - Healthcare Information Services · US
$8.73
+26.89%Year over year
Reported trailing growth
- Revenue
- -2.4%
- EBITDA
- +140.6%
- EBIT
- +45.5%
- EPS
- +32.8%
- Free cash flow
- +17.1%
- Operating cash flow
- -8.3%
Forward estimates
Based on analyst estimates
- Revenue
- -3.9%
- EBITDA
- -9.6%
- EPS
- +20.8%
Three-year CAGR
- Revenue
- +1.7%
- EBITDA
- +43.1%
- EBIT
- +74.2%
- Net income
- +80.0%
- EPS
- +80.6%
- Free cash flow
- +18.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026